Glaukos (GKOS) Technical Analysis

Glaukos Corp (GKOS) is a company engaged in the field of ophthalmic medical technology. It specializes in developing and commercializing innovative solutions for the treatment of glaucoma, a leading cause of blindness worldwide. As a pioneer in the use of micro-invasive glaucoma surgery (MIGS), Glaukos Corp has established itself as a leader in this rapidly growing market.

Technical analysis of Glaukos Corp stock (GKOS) involves the use of various indicators to analyze price movements and identify potential trends. One commonly used indicator is the relative strength index (RSI), which measures the magnitude of recent price changes to determine if the stock is overbought or oversold. Another indicator is the average directional index (ADX), which measures the strength of a trend. The moving average convergence divergence (MACD) is also frequently used to identify potential buy or sell signals. Other indicators like the rate of change (ROC), stochastic relative strength index (STOCHRSI), and Williams %R (WILLR) provide additional insights into the stock's momentum and potential reversals.